Matica Completes Review of Second ACMPR Application

September 8, 2017 – Toronto, Ontario – Matica Enterprises Inc. (MMJ–CSE) (39N – Frankfurt) (MQPXF – OTC PINK) (“Matica” or the “Company”) is pleased to report that the Company has completed its due diligence on the second application under the Access To Cannabis for Medical Purposes Regulation (“ACMPR”) in Quebec. This second application was first reported on in a News Release on July 20, 2017.  The Company has renegotiated terms and is now proceeding towards a definitive agreement based on a newly amended letter of intent.

Management of Matica again toured the work site of the Dorval facility to inspect on progress.  We are pleased to report significant progress towards completion of the project has been made. Preparations for the HVAC installation are underway.  The electrical system upgrades are nearing completion, as is the construction of the extended capacity vault.

Matica Enterprises CEO, Boris Ziger states, “I am pleased to see a busy work site at Dorval and anticipate that we will complete construction on time in November, as planned.


For more information on Matica please visit the website at: or follow us on Twitter at @MaticaMMJ.


On behalf of the Board of Directors


/s/Boris Ziger

Boris Ziger, CEO & Chairman


The Company’s filings are available for review at and

For further information, please contact Boris Ziger, Chief Executive Officer, at:

Telephone: 416-304-9935




Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at

The CSE has not reviewed, approved or disapproved the content of this press release.